リコンビナント
RabMAb

Anti-IRS1 抗体 [EP263Y] (ab40777)

ab40777 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab40777 は 8 報の論文で使用されています。

  • Luo J  et al. Elevated Expression of IRS-1 Associates with p-Akt Expression and Predicts Poor Prognosis of Breast Invasive Ductal Carcinoma. Hum Pathol N/A:N/A (2018). PubMed: 29551677
  • Wang S  et al. SH2B1 promotes epithelial-mesenchymal transition through the IRS1/ß-catenin signaling axis in lung adenocarcinoma. Mol Carcinog 57:640-652 (2018). WB ; Human . PubMed: 29380446
  • Vishwamitra D  et al. The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK? T-cell lymphoma. Mol Cancer 14:53 (2015). PubMed: 25884514
  • El-Ami T  et al. A novel inhibitor of the insulin/IGF signaling pathway protects from age-onset, neurodegeneration-linked proteotoxicity. Aging Cell 13:165-74 (2014). PubMed: 24261972
  • Lovly CM  et al. Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer. Nat Med 20:1027-34 (2014). PubMed: 25173427
  • Luo J  et al. Increased expression of IRS-1 is associated with lymph node metastasis in nasopharyngeal carcinoma. Int J Clin Exp Pathol 7:6117-24 (2014). IHC ; Human . PubMed: 25337259
  • Chatterjee S  et al. Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. J Clin Invest 123:1732-40 (2013). IHC-P ; Human . PubMed: 23454747
  • Liu S  et al. Antisense treatment of IGF-IR enhances chemosensitivity in squamous cell carcinomas of the head and neck. Eur J Cancer 46:1744-51 (2010). PubMed: 20451373

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録